ZFN |
Zinc-finger Nucleases |
TALEN |
Transcription Activator-like Effector Nucleases |
CRISPR |
Clustered Regularly Interspaced Short Palindrome Repeats |
hiPSCs |
Human induced Pluripotent Stem Cells |
hPSCs |
Human Pluripotent stem cells |
hESCs |
Human Embryonic Stem Cells |
HIV-1 |
Human Immunodeficiency Virus |
tracrRNA |
trans-activating crRNA |
sgRNA |
single-guide RNA |
IV |
Intravenous |
saCas9 |
Staphylococcus aureus Cas9 |
MPS II |
Mucopolysaccharidosis II |
IDS |
Iduronate 2-Sulfatase |
CNS |
Central Nervous System |
HPV |
Human Papillomavirus |
HTI |
Hereditary Tyrosinemia Type I |
AMD |
Age-related Macular Degeneration |
DMD |
Duchenne Muscular Dystrophy |
ALS |
Amyotrophic Lateral Sclerosis |
OTC |
Ornithine Transcarbamylase |
AAT |
Alpha-1 antitrypsin |
LCA |
Leber’s congenital amaurosis |
HR |
Homologous Recombination |
DTA |
Diphtheria A |
CCR |
Chemokine Co-Receptor |
ERT |
Enzyme Replacement Therapy |
ART |
Anti-retroviral therapy |
NSG |
NOD/SCID/IL2rγnull |
SOD1 |
Superoxide Dismutase 1 |
rAAV |
Recombinant Adeno-Associated Viruses |
AAV |
Adeno-Associated Viruses |
BLT |
Bone marrow/liver/thymus |
SMA |
Spinal Muscular Atrophy |
MHC |
Major Histocompatibility Complex |
PLNP |
Polyethylene glycol phospholipid-modified cationic lipid nanoparticle |
CNS |
Central nervous system |
BBB |
Blood brain barrier |
MOI |
Multiplicity of infection |
NPs |
Nanoparticles |